
Pancreatic ductal adenocarcinoma (PDAC) screening is recommended for high-risk individuals (HRI) with familial pancreatic cancer (FPC) or certain pathogenic germline variants (PGVs). Screening MRI commonly identifies pancreatic cystic lesions (PCLs), but comparative data between HRI and average-risk...

Noninvasive prognostic biomarkers are needed for patients receiving immune checkpoint inhibitors (ICIs). We evaluated whether ultrasound-derived spatial heterogeneity indices (SHI) from intra- and peritumoral regions of liver metastases from solid cancers-measured at baseline, at first evaluation, and...